In the present work, using a background of natural overexpression of Grb2 in AD mouse brain and in human AD brain lysates, we aimed to study the expression levels of cytoskeletal proteins in AD-like conditions along with the effects of Grb2 on them, and we discuss our results in the context of pathways that may be perturbed. The gene discussed is GRB2; the disease is Alzheimer disease.